Marie-Carmelle Elie

Marie-Carmelle Elie, M.D., RDMS, FACEP, FCCM

Adjunct Professor

Department: Department of Emergency Medicine
Business Phone: (352) 265-5911

Teaching Profile

Courses Taught
2018
MDT7710 Elec Topic Emerg Med
2018
MDT7090 Elective Topics
2018
MDC7710 Sr Emerg Med Clerkshp
2018
MDC7400 Pediatric Clerkship
2014
GMS6029 Brain Journal Club

Board Certifications

  • Emergency Medicine
    American Board of Emergency Medicine

Publications

2023
Avoidance-Endurance Model in Older Black Men with Low Back Pain: Exploring Relationships.
Journal of racial and ethnic health disparities. 10(3):1310-1318 [DOI] 10.1007/s40615-022-01316-4. [PMID] 35501598.
2021
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
The New England journal of medicine. 384(9):795-807 [DOI] 10.1056/NEJMoa2031994. [PMID] 33306283.
2021
Comparison of fluid resuscitation weight-based dosing strategies in obese patients with severe sepsis.
The American journal of emergency medicine. 49:268-272 [DOI] 10.1016/j.ajem.2021.06.036. [PMID] 34171722.
2021
Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial Cohort.
Critical care explorations. 3(7) [DOI] 10.1097/CCE.0000000000000474. [PMID] 34278310.
2018
Development of a personalized diagnostic model for kidney stone disease tailored to acute care by integrating large clinical, demographics and laboratory data: the diagnostic acute care algorithm – kidney stones (DACA-KS).
BMC medical informatics and decision making. 18(1) [DOI] 10.1186/s12911-018-0652-4. [PMID] 30119627.
2016
The incidence and significance of acute kidney injury following emergent contrast administration in patients with STEMI and stroke.
Internal and emergency medicine. 11(6):853-7 [DOI] 10.1007/s11739-016-1407-9. [PMID] 26910240.
2016
Trauma Simulation Training Increases Confidence Levels in Prehospital Personnel Performing Life-Saving Interventions in Trauma Patients.
Emergency medicine international. 2016 [DOI] 10.1155/2016/5437490. [PMID] 27563467.
2015
An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA.
Clinical toxicology (Philadelphia, Pa.). 53(10):950-6 [DOI] 10.3109/15563650.2015.1100306. [PMID] 26555732.
2015
Evaluation of healthcare use trends of high-risk female intimate partner violence victims.
The western journal of emergency medicine. 16(1):107-13 [DOI] 10.5811/westjem.2014.12.22866. [PMID] 25671018.
2015
Palliative Care Symptom Management.
Critical care nursing clinics of North America. 27(3):315-39 [DOI] 10.1016/j.cnc.2015.05.010. [PMID] 26333754.
2013
Contemporary ventilator management in patients with and at risk of ALI/ARDS.
Respiratory care. 58(4):578-88 [DOI] 10.4187/respcare.01755. [PMID] 22906363.
2013
Emergency department crowding and time to antibiotic administration in febrile infants.
The western journal of emergency medicine. 14(5):518-24 [DOI] 10.5811/westjem.2013.1.14693. [PMID] 24106552.
2006
Blunt cardiac injury.
The Mount Sinai journal of medicine, New York. 73(2):542-52 [PMID] 16568196.

Grants

Oct 2020 ACTIVE
COVID-19: A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19
Role: Project Manager
Funding: NEW YORK UNIV via NATL INST OF HLTH NHLBI
Aug 2020 – Aug 2020
Passive Immunity Trial for Our Neighbors (PassItOn): A randomized, placebocontrolled multi-site trial of anti-SARS-CoV-2 convalescent plasma to treat hospitalized adults with COVID-19
Role: Principal Investigator
Funding: VANDERBILT UNIVERSITY MEDICAL CENTER via NATL INST OF HLTH NCATS
Apr 2020 – Jul 2020
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)
Role: Principal Investigator
Funding: BAYSTATE MEDICAL CENTER via NATL INST OF HLTH NHLBI
Mar 2020 – Aug 2021
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
Role: Co-Investigator
Funding: LEIDOS via NATL INST OF HLTH NIAID
Sep 2019 ACTIVE
ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
Role: Project Manager
Funding: STANFORD UNIV via NATL INST OF HLTH NHLBI
Sep 2018 – Apr 2021
Acute Lung Injury Group New England Program to Support PETAL Network Research (PETAL Core)
Role: Principal Investigator
Funding: BAYSTATE MEDICAL CENTER via NATL INST OF HLTH NHLBI
May 2018 – Jun 2023
Primary Palliative Care for Emergency Medicine
Role: Project Manager
Funding: NEW YORK UNIVERSITY SCHOOL OF MEDICINE via NATL CTR FOR COMPLEM AND INTEGRATIVE HLT
Dec 2017 – Nov 2023
Emergency Medicine-Initiated Palliative Care In Older Adults (EMPallA)
Role: Project Manager
Funding: NEW YORK UNIVERSITY SCHOOL OF MEDICINE via PATIENT-CENTERED OUTCOMES RES INST
Aug 2016 – Sep 2018
A Randomized Double-Blind Study Comparing Oseltamivir versus Placebo for the Treatment of Influenza in Low Risk Adults
Role: Principal Investigator
Funding: SOCIAL AND SCIENTIFIC SYSTEMS via NATL INST OF HLTH NIAID
Jan 2016 – Jun 2018
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity with Enteric LB1148 (SSAIL Study)
Role: Principal Investigator
Funding: PPD INVESTIGATOR SERVICES LLC via LEADING BIOSCIENCES
Nov 2015 – Sep 2016
A RANDOMIZED DOUBLE BLIND PHASE 2 STUDY COMPARING THE EFFICACY, SAFETY, AND TOLERABILITY OF COMBINATION ANTIVIRALS (Amantadine, Ribavirin,Oseltamivir) versus Oseltamivir for the Treatment of Influenza
Role: Principal Investigator
Funding: SOCIAL AND SCIENTIFIC SYSTEMS via NATL INST OF HLTH NIAID
Nov 2015 – Jun 2016
A Randomized Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-Influenza Immune Plasma for the Treatment of Influenza
Role: Principal Investigator
Funding: SOCIAL AND SCIENTIFIC SYSTEMS via NATL INST OF HLTH NIAID
Oct 2015 – Jun 2019
a randomized double blind phase 3 study comparing the efficacy and safety of high titer versus low titer anti influenza immune plasma for the treatment of severe influenza
Role: Principal Investigator
Funding: SOCIAL AND SCIENTIFIC SYSTEMS via NATL INST OF HLTH NIAID
Apr 2015 – Oct 2015
Influenza Studies IRC003 and IRC004 Domestic Operations
Role: Principal Investigator
Funding: SOCIAL AND SCIENTIFIC SYSTEMS via LEIDOS
Jan 2014 – Jan 2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study Evaluating the Safety and Efficacy of Icatibant as a Treatment for Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema in Adults
Role: Principal Investigator
Funding: SHIRE PHARMACEUTICAL DEV

Contact Details

Phones:
Business:
(352) 265-5911
Human Resources:
Addresses:
Business Mailing:
PO Box 100186
GAINESVILLE FL 32610
Business Street:
Department of Emergency Medicine
1329 SW 16th Street, Suite 5270
Gainesville FL 32608